Drug Type Small molecule drug |
Synonyms Lathanol, Lathanol LAL, Sulfoacetic acid dodecyl ester S-sodium salt + [2] |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date China (01 Jan 2004), |
Regulation- |
Molecular FormulaC14H28NaO5S |
InChIKeyMCNJOIMMYWLFBA-UHFFFAOYSA-N |
CAS Registry1847-58-1 |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | - | - |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Pelvic Inflammatory Disease | China | 01 Jan 2004 | |
| Respiratory Tract Infections | China | 01 Jan 2004 | |
| Uterine Cervicitis | China | 01 Jan 2004 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Candidiasis | Preclinical | China | 01 Jun 2025 | |
| Invasive Pulmonary Aspergillosis | Preclinical | China | 01 May 2025 | |
| Invasive Pulmonary Aspergillosis | Preclinical | China | 01 May 2025 |





